Reviewing Avivagen (OTCMKTS:VIVXF) and Covestro (OTC:COVTY)

Avivagen (OTCMKTS:VIVXF) and Covestro (OTC:COVTY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability.

Valuation & Earnings

This table compares Avivagen and Covestro”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avivagen	$730,000.00	0.00	-$4.71 million	N/A	N/A
Covestro	$15.56 billion	0.84	-$214.29 million	($1.10)	-31.35

Avivagen has higher earnings, but lower revenue than Covestro.

Profitability

This table compares Avivagen and Covestro’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avivagen	N/A	N/A	N/A
Covestro	-1.84%	-3.91%	-1.89%

Risk and Volatility

Avivagen has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Comparatively, Covestro has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Avivagen and Covestro, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avivagen	0	0	0	0	0.00
Covestro	0	2	0	0	2.00

Given Avivagen’s higher possible upside, equities analysts clearly believe Avivagen is more favorable than Covestro.

Summary

Avivagen beats Covestro on 5 of the 8 factors compared between the two stocks.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

About Covestro

Covestro AG supplies high-tech polymer materials and application solutions. It operates in two segments, Performance Materials, and Solutions & Specialties. The Performance Materials segment develops, produces, and supplies high-performance materials, such as polyurethanes and polycarbonates, and base chemicals, which include diphenylmethane diisocyanate (MDI), toluylene diisocyanate, long-chain polyols, and polycarbonate resins for use in furniture and wood processing, construction, automotive, and transportation industries, as well as roof structures, insulation for buildings and refrigerators, mattresses, car seats, and other applications. The Solutions & Specialties segment comprises a range of polymer products, including polycarbonates, precursors for coatings and adhesives, MDI specialties and polyols, thermoplastic polyurethanes, specialty films, and elastomers that are used in automotive and transportation, electrical, electronics and household appliances, construction, and healthcare industries, as well as composite resins for solar panel frames, laptops, floodlights, and electric vehicle batteries. The company markets its products through trading houses and distributors. It operates in Europe, the Middle East, Africa, Latin America, the United States, Canada, and the People’s Republic of China. The company was founded in 1863 and is headquartered in Leverkusen, Germany.